VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 52 filers reported holding VOR BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,227,626 | -31.4% | 22,748,880 | 0.0% | 0.95% | -28.5% |
| Q2 2023 | $70,294,039 | -42.6% | 22,748,880 | 0.0% | 1.33% | -52.1% |
| Q1 2023 | $122,388,974 | -19.1% | 22,748,880 | 0.0% | 2.77% | -9.7% |
| Q4 2022 | $151,280,052 | +241.8% | 22,748,880 | +104.6% | 3.07% | +225.0% |
| Q3 2022 | $44,261,000 | -19.9% | 11,120,973 | 0.0% | 0.94% | -36.0% |
| Q2 2022 | $55,271,000 | -17.7% | 11,120,973 | 0.0% | 1.47% | +0.5% |
| Q1 2022 | $67,171,000 | -48.0% | 11,120,973 | 0.0% | 1.47% | -35.6% |
| Q4 2021 | $129,226,000 | -25.9% | 11,120,973 | 0.0% | 2.28% | -5.7% |
| Q3 2021 | $174,377,000 | -15.9% | 11,120,973 | 0.0% | 2.42% | -27.4% |
| Q2 2021 | $207,406,000 | -56.7% | 11,120,973 | 0.0% | 3.33% | -53.9% |
| Q1 2021 | $479,314,000 | – | 11,120,973 | – | 7.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $13,486,853 | 3.88% |
| OUP Management Co., LLC | 374,714 | $794,394 | 1.79% |
| RA Capital Management | 22,748,880 | $48,227,626 | 0.95% |
| Paradigm Biocapital Advisors LP | 6,461,467 | $13,698,310 | 0.93% |
| JOHNSON & JOHNSON | 1,074,658 | $2,278,275 | 0.84% |
| Trustees of Columbia University in the City of New York | 91,910 | $194,849 | 0.36% |
| Artal Group S.A. | 2,688,015 | $5,699 | 0.24% |
| Sarissa Capital Management LP | 618,000 | $1,310,160 | 0.18% |
| Laurion Capital Management LP | 3,182,889 | $6,747,724 | 0.04% |
| Woodline Partners LP | 1,111,123 | $2,355,581 | 0.03% |